| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(96)00631-0 |
| P698 | PubMed publication ID | 8960884 |
| P50 | author | Billy R Martin | Q60467790 |
| P2093 | author name string | D R Compton | |
| S R Fernando | |||
| G Griffin | |||
| R K Razdan | |||
| R G Pertwee | |||
| W Ryan | |||
| P2860 | cites work | SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 |
| Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine | Q35872513 | ||
| Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine | Q35874121 | ||
| Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide | Q36330025 | ||
| pA2 and receptor differentiation: a statistical analysis of competitive antagonism | Q39813802 | ||
| Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study | Q42617028 | ||
| Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment | Q48209713 | ||
| The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. | Q52754983 | ||
| Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens | Q71149812 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 195-201 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. | |
| P478 | volume | 315 |
| Q44228316 | (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens |
| Q33861944 | An investigation into the structural determinants of cannabinoid receptor ligand efficacy |
| Q33876516 | Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. |
| Q34454662 | Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. |
| Q24676188 | Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist |
| Q24646822 | Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist |
| Q41904764 | Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors |
| Q74184497 | Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat |
| Q35045710 | Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release |
| Q47787266 | Medial prefrontal cannabinoid CB1 receptors modulate consolidation and extinction of cocaine-associated memory in mice |
| Q34430714 | Modulation of transmitter release via presynaptic cannabinoid receptors |
| Q40784670 | Neuropharmacology and therapeutic potential of cannabinoids |
| Q40083173 | Novel, potent THC/anandamide (hybrid) analogs. |
| Q34442847 | Pharmacology of cannabinoid CB1 and CB2 receptors. |
| Q37226537 | Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). |
| Q34152254 | Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist. |
| Q33876520 | Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors |
| Q34002108 | The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo |
| Q33906007 | Towards cannabinoid drugs--revisited. |
Search more.